Parameters | Base-case | Reference |
---|---|---|
HIV Epidemiology | ||
Number of HIV-infected pregnant women | 2000 | Surveillance data |
Percentage of pregnant women with CD4 count> 350 cells/μl(%) | 64 | Surveillance data |
MTCT transmission rates | ||
Background transmission rate without intervention (%) | 34.80 | Surveillance data |
Transmission rate, Option A with infant prophylaxis, formula feeding(%) | 7.28 | Surveillance data |
Transmission rate, Option B, Option B+ and eligible women on ART With infant prophylaxis, formula feeding(%) | 3.86(1.00–5.00) | Surveillance data, [20] |
Delivery proportion(%) | 55.79 | Surveillance data |
Newborn mortality rate | 0.0069 | China Health Statistical Yearbook 2013 |
Health utility | 0.74 | [21] |
Cost | ||
HIV testing and counselling | US$4.06 | Surveillance data |
CD4 screening | US$52.24 | Surveillance data |
Drugs in Option A | US$23.94 | Surveillance data |
Drugs in Option B and Option B+(until 42 days after delivery) | US$235.65 | Surveillance data |
Infant ARVs prophylaxis | US$18.14 | Surveillance data |
Formula feeding | US$580.42 | Surveillance data |
Infant diagnosis | US$26.12 | Surveillance data |
Discounted lifetime cost for an HIV infected child on ART(69.5 years) | US$247,163.94 | [19] |